Medelis, Inc.

About

Medelis Inc is a specialized oncology Contract Research Organization based in Nashville, Tennessee, providing comprehensive drug development services for biotech and pharmaceutical sponsors. As a dedicated oncology CRO since 2008, Medelis focuses exclusively on phase I through phase III oncology trials, leveraging deep expertise in immuno-oncology and extensive investigator relationships across three continents. The company has successfully completed over 150 projects, demonstrating proven capabilities in pharmaceuticals, devices, and combination products. Medelis offers end-to-end services including study design, study launch, and study management, complemented by medical writing, drug development consulting, and study rescue capabilities. Their collaborative approach emphasizes relationships as their primary priority, delivering transparent pricing and cost certainty throughout project lifecycles. The organization maintains dedicated project managers and specialized oncology expertise at every trial stage, enabling rapid study start-up and flexible resourcing solutions. What distinguishes Medelis in the competitive pharmaceutical research landscape is their laser focus on oncology indications combined with rapid deployment capabilities and comprehensive regulatory compliance expertise. Their experienced team provides strategic guidance and operational excellence, helping sponsors navigate complex drug development pathways efficiently. By maintaining strong investigator networks and delivering consistent quality standards, Medelis has established itself as a trusted partner for organizations developing innovative cancer therapies and advancing oncology research.